Posted on 5/10/17
Revista Adds Capital One Healthcare As A Partner
Revista, the nation’s healthcare real estate information leader, recently announced the addition of a new Platinum Partner, Capital One Healthcare, and accompanying member, Erik Tellefson, to . . .
Posted on 5/10/17
Novavax: Earnings Call Review And Assessment Of The Multi-Arm RSV Trial
I had to undergo surgery a few months ago and the recovery wiped out most of my time, so it's taken me much longer than expected . . .
Posted on 5/10/17
Novavax, Inc Is Rising Today, but You Should Still Stay Far Away
What happenedIn response to reporting first-quarter earnings, shares of Novavax (NASDAQ:NVAX), a clinical-stage biotech focused on vaccines, jumped 22% as of 11:25 a.m. EDT on Tuesday.So . . .
Posted on 5/10/17
American Telemedicine Association and ClearHealth Quality Institute Announce Joint Venture
American Telemedicine Association (ATA) and ClearHealth Quality Institute™ (CHQI) announce a joint venture to develop the next generation of Telemedicine Accreditation Standards. This dynamic collaboration will . . .
Posted on 5/9/17
Companies Selected as Finalists for the Maryland Incubator Company of the Year Awards from BHI-lead incubators
Twenty-one of the State’s leading incubator companies have been selected as finalists for the 2017 Maryland Incubator Company of the Year Awards. The team from BioHealth . . .
Posted on 5/9/17
Novavax's (NVAX) CEO Stan Erck on Q1 2017 Results - Earnings Call Transcript
Novavax, Inc. (NASDAQ:NVAX)Q1 2017 Earnings Conference CallMay 08, 2017 04:30 PM ETExecutivesStan Erck - CEOBuck Phillips - CFOGreg Glenn - President R&DAnalystsJoel Beatty - CitiTed Tenthoff . . .
Posted on 5/9/17
Emergent Biosolutions Inc. Moves Things Around, Still Sees Growth
Emergent BioSolutions (NYSE:EBS) released earnings last week, setting itself up for a solid year as it moves toward its goal of having $1 billion in revenue . . .
Posted on 5/5/17
Rexahn Effects 1-for-10 Reverse Stock Split
ROCKVILLE, Md., May 05, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of . . .
Posted on 5/4/17
ECAN Petitions FDA for New Labels on Over-the-Counter Reflux Medications Warning about the Risk of Esophageal Cancer
BALTIMORE– One American dies of esophageal cancer every 36 minutes and the type of esophageal cancer caused by reflux disease is the fastest increasing cancer among . . .
Posted on 5/3/17
PharmAthene Reports Q1 2017 Financial and Operational Results
PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the first quarter of 2017. . . .
Posted on 5/2/17
Medifast Earns Spot on Forbes' 100 Most Trustworthy Companies in America List for Second Consecutive Year
Medifast, Inc. (NYSE: MED), is proud to announce it has been named to the 2017 Forbes 100 Most Trustworthy Companies in America list for the second . . .
Posted on 5/2/17
Sirnaomics Received IND Approval from CFDA
Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announces today that its subsidiary company, Suzhou Sirnaomics Pharmaceuticals, Co. Ltd, China, . . .
Posted on 5/1/17
Salubris Pharmaceuticals Celebrates Ribbon Cutting of New Research & Development Lab
Salubris Pharmaceuticals opened their new research & development laboratory today at 10:30 AM at 45
Posted on 5/2/17
McDermott+Consulting Appoints Adaeze Enekwechi VP
McDermott+Consulting is pleased to announce the arrival of Adaeze Enekwechi, PhD, MPP as Vice President.
Posted on 5/1/17
FDA Approves New Combination Treatment For Acute Myeloid Leukemia
The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a . . .
Posted on 5/1/17
CEL-SCI Receives Intent to Grant Notice for New Multikine Patent from the European Patent Office
CEL-SCI Corporation (NYSE MKT: CVM) today announced that it has been notified that it will be granted a new patent on Multikine* (Leukocyte Interleukin, Injection), its investigational cancer immunotherapy, . . .
Posted on 4/28/17
United Therapeutics Announces $250 Million Share Repurchase Program
United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to $250 million of the company's common stock. This . . .
Posted on 4/27/17
MacroGenics Raises $23.6M
A clinical-stage biopharmaceuticals company raised $23.6 million by selling 1.1 million shares to an investor, according
Posted on 4/26/17
PharmAthene and Altimmune Announce Combined Company Approved for Trading on Nasdaq Global Market
ANNAPOLIS, Md. and GAITHERSBURG, Md., April 26, 2017 (GLOBE NEWSWIRE) -- As previously announced, PharmAthene, Inc. (NYSE MKT:PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting . . .
Posted on 4/26/17
United Therapeutics Corporation Reports First Quarter 2017 Financial Results
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2017."Our quarterly financial growth trends are slower than we . . .
Posted on 4/26/17
3D Systems and United Therapeutics Announce Bioprinting Agreement
3D Systems (NYSE: DDD) and United Therapeutics Corporation (NASDAQ: UTHR) today announced plans to develop solid-organ scaffolds for human transplants. The multi-year collaboration and development agreement . . .
Posted on 4/26/17
Spanish Biotech Company To Locate U.S. Operations In Virginia Beach
A Spanish biotech company, One Way Liver S.L. (OWL Metabolomics), plans to open its U.S. headquarters in the VABeachBio Accelerator in Virginia Beach as part of . . .
Posted on 4/25/17
Omega Healthcare Bumps CEO Taylor Pickett’s Bonus Up 25 Percent After Strong Earnings
Omega Healthcare Investors Inc. paid Chief Executive Officer Taylor Pickett $6.7 million in compensation in 2016, up from $6 million in 2015, according to a filing . . .
Posted on 4/25/17
BrainScope One Revolutionizes Brain Injury Assessment for Urgent Care Clinics
BETHESDA, Md.--(BUSINESS WIRE)--BrainScope Company, Inc. today announced it will unveil its new FDA-cleared, objective comprehensive head injury assessment device, BrainScope One, at Momentum 2017: UCAOA Urgent . . .
Posted on 4/25/17
Biologics Consulting Assists Briacell Therapeutics In Gaining FDA Clearance
Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, announced today that its Chemistry, Manufacturing, and Controls (CMC) Specialty . . .
Washington DC
